TY - JOUR AU - Shah, M. Y. AU - Ferrajoli, A. AU - Sood, A. K. AU - Lopez-Berestein, G. AU - Calin, G. A. PY - 2016 DA - 2016// TI - Microrna therapeutics in cancer - an emerging concept JO - EBioMedicine VL - 12 UR - https://doi.org/10.1016/j.ebiom.2016.09.017 DO - 10.1016/j.ebiom.2016.09.017 ID - Shah2016 ER - TY - JOUR AU - Buchan, J. R. AU - Parker, R. PY - 2007 DA - 2007// TI - The two faces of miRNA JO - Science VL - 318 UR - https://doi.org/10.1126/science.1152623 DO - 10.1126/science.1152623 ID - Buchan2007 ER - TY - JOUR AU - Goh, J. N. AU - Loo, S. Y. AU - Datta, A. AU - Siveen, K. S. AU - Yap, W. N. AU - Cai, W. AU - Shin, E. M. AU - Wang, C. AU - Kim, J. E. AU - Chan, M. PY - 2016 DA - 2016// TI - microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer JO - Biol Rev VL - 91 UR - https://doi.org/10.1111/brv.12176 DO - 10.1111/brv.12176 ID - Goh2016 ER - TY - JOUR AU - Yamashita, R. AU - Sato, M. AU - Kakumu, T. AU - Hase, T. AU - Yogo, N. AU - Maruyama, E. AU - Sekido, Y. AU - Kondo, M. AU - Hasegawa, Y. PY - 2015 DA - 2015// TI - Growth inhibitory effects of mir-221 and mir-222 in non-small cell lung cancer cells JO - Cancer Med VL - 4 UR - https://doi.org/10.1002/cam4.412 DO - 10.1002/cam4.412 ID - Yamashita2015 ER - TY - JOUR AU - Brioschi, M. AU - Fischer, J. AU - Cairoli, R. AU - Rossetti, S. AU - Pezzetti, L. AU - Nichelatti, M. AU - Turrini, M. AU - Corlazzoli, F. AU - Scarpati, B. AU - Morra, E. PY - 2010 DA - 2010// TI - Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits JO - Neoplasia VL - 12 UR - https://doi.org/10.1593/neo.10482 DO - 10.1593/neo.10482 ID - Brioschi2010 ER - TY - JOUR AU - Henry, J. C. AU - Azevedo-Pouly, A. C. P. AU - Schmittgen, T. D. PY - 2011 DA - 2011// TI - MicroRNA replacement therapy for cancer JO - Pharm Res VL - 28 UR - https://doi.org/10.1007/s11095-011-0548-9 DO - 10.1007/s11095-011-0548-9 ID - Henry2011 ER - TY - JOUR AU - Krützfeldt, J. AU - Rajewsky, N. AU - Braich, R. AU - Rajeev, K. G. AU - Tuschl, T. AU - Manoharan, M. AU - Stoffel, M. PY - 2005 DA - 2005// TI - Silencing of microRNAs in vivo with ’antagomirs’ JO - Nature VL - 438 UR - https://doi.org/10.1038/nature04303 DO - 10.1038/nature04303 ID - Krützfeldt2005 ER - TY - JOUR AU - Esquela-Kerscher, A. AU - Trang, P. AU - Wiggins, J. F. AU - Patrawala, L. AU - Cheng, A. AU - Ford, L. AU - Weidhaas, J. B. AU - Brown, D. AU - Bader, A. G. AU - Slack, F. J. PY - 2008 DA - 2008// TI - The let-7 microRNA reduces tumor growth in mouse models of lung cancer JO - Cell Cycle VL - 7 UR - https://doi.org/10.4161/cc.7.6.5834 DO - 10.4161/cc.7.6.5834 ID - Esquela-Kerscher2008 ER - TY - JOUR AU - Trang, P. AU - Wiggins, J. F. AU - Daige, C. L. AU - Cho, C. AU - Omotola, M. AU - Brown, D. AU - Weidhaas, J. B. AU - Bader, A. G. AU - Slack, F. J. PY - 2011 DA - 2011// TI - Systemic delivery of tumor suppressor microRNAs mimics using a neutral lipid emulsion inhibits lung tumors in mice JO - Mol Ther VL - 19 UR - https://doi.org/10.1038/mt.2011.48 DO - 10.1038/mt.2011.48 ID - Trang2011 ER - TY - JOUR AU - Rupaimoole, R. AU - Slack, F. J. PY - 2017 DA - 2017// TI - MicroRNA therapeutics: towards a new era for the management of cancer and other diseases JO - Nat Rev Drug Discov VL - 16 UR - https://doi.org/10.1038/nrd.2016.246 DO - 10.1038/nrd.2016.246 ID - Rupaimoole2017 ER - TY - JOUR AU - Calin, G. A. AU - Croce, C. M. PY - 2009 DA - 2009// TI - Chronic lymphocytic leukemia: interplay between noncoding rnas and protein-coding genes JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-07-192740 DO - 10.1182/blood-2009-07-192740 ID - Calin2009 ER - TY - JOUR AU - Yuan, T. L. AU - Fellmann, C. AU - Lee, C. -. S. AU - Ritchie, C. D. AU - Thapar, V. AU - Lee, L. C. AU - Hsu, D. J. AU - Grace, D. AU - Carver, J. O. AU - Zuber, J. PY - 2014 DA - 2014// TI - Development of sirna payloads to target kras-mutant cancer JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0900 DO - 10.1158/2159-8290.CD-13-0900 ID - Yuan2014 ER - TY - JOUR AU - Lieberman, J. AU - Sarnow, P. PY - 2013 DA - 2013// TI - Micromanaging hepatitis c virus JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMe1301348 DO - 10.1056/NEJMe1301348 ID - Lieberman2013 ER - TY - STD TI - Layek R, Datta A, Bittner M, Dougherty ER. Cancer therapy design based on pathway logic. Bioinformatics. 2011; 27(4):548–55. https://doi.org/10.1093/bioinformatics/btq703. ID - ref14 ER - TY - STD TI - Arshad OA, Datta A. Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer. BMC Bioinforma. 2017; 18(4):134. https://doi.org/10.1186/s12859-017-1522-2. ID - ref15 ER - TY - STD TI - Layek RK, Datta A, Dougherty ER. From biological pathways to regulatory networks. Mol BioSyst. 2011; 7:843–51. https://doi.org/10.1039/C0MB00263A. ID - ref16 ER - TY - STD TI - Sridharan S., Varghese R., Venkatraj V., Datta A.Hypoxia stress response pathways: Modeling and targeted therapy. IEEE J Biomed Health Informa. 2017; 21(3):875–85. https://doi.org/10.1109/JBHI.2016.2559460. ID - ref17 ER - TY - STD TI - Lin P-CK, Khatri SP. Application of max-sat-based atpg to optimal cancer therapy design. BMC Genomics. 2012; 13(6):5. https://doi.org/10.1186/1471-2164-13-S6-S5. ID - ref18 ER - TY - STD TI - Mohanty A. K., Datta A., Venkatraj V.Using the message passing algorithm on discrete data to detect faults in boolean regulatory networks. Algoritm Mol Biol. 2014; 9(1):20. https://doi.org/10.1186/s13015-014-0020-6. ID - ref19 ER - TY - STD TI - Mohanty AK, Datta A, Venkatraj V. A model for cancer tissue heterogeneity. IEEE Trans Biomed Eng. 2014; 61(3):966–74. https://doi.org/10.1109/TBME.2013.2294469. ID - ref20 ER - TY - STD TI - Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016; 44(D1):457–62. https://doi.org/10.1093/nar/gkv1070. ID - ref21 ER - TY - STD TI - Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014; 42(D1):980–5. https://doi.org/10.1093/nar/gkt1113. ID - ref22 ER - TY - STD TI - Zhao M, Kim P, Mitra R, Zhao J, Zhao Z. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res. 2016; 44(D1):1023–31. https://doi.org/10.1093/nar/gkv1268. ID - ref23 ER - TY - STD TI - An O., Dall’Olio G. M., Mourikis T. P., Ciccarelli F. D.NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings. Nucleic Acids Res. 2016; 44(D1):992–9. https://doi.org/10.1093/nar/gkv1123. ID - ref24 ER - TY - STD TI - The UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 2015; 43(D1):204–12. https://doi.org/10.1093/nar/gku989. ID - ref25 ER - TY - STD TI - Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018; 46(D1):1074–82. https://doi.org/10.1093/nar/gkx1037. ID - ref26 ER - TY - JOUR AU - Chou, C. -. H. AU - Shrestha, S. AU - Yang, C. -. D. AU - Chang, N. -. W. AU - Lin, Y. -. L. AU - Liao, K. -. W. AU - Huang, W. -. C. AU - Sun, T. -. H. AU - Tu, S. -. J. AU - Lee, W. -. H. PY - 2017 DA - 2017// TI - miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions JO - Nucleic Acids Res VL - 46 UR - https://doi.org/10.1093/nar/gkx1067 DO - 10.1093/nar/gkx1067 ID - Chou2017 ER - TY - STD TI - Fiannaca A., La Rosa M., La Paglia L., Urso A.miRTissue: a web application for the analysis of miRNA-target interactions in human tissues. BMC Bioinforma. 2018; 19(S15):434. https://doi.org/10.1186/s12859-018-2418-5. ID - ref28 ER - TY - JOUR AU - Lynch, T. J. AU - Bell, D. W. AU - Sordella, R. AU - Gurubhagavatula, S. AU - Okimoto, R. A. AU - Brannigan, B. W. AU - Harris, P. L. AU - Haserlat, S. M. AU - Supko, J. G. AU - Haluska, F. G. PY - 2004 DA - 2004// TI - Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa040938 DO - 10.1056/NEJMoa040938 ID - Lynch2004 ER - TY - JOUR AU - Tong, B. AU - Xu, Y. AU - Zhao, J. AU - Chen, M. AU - Zhong, W. AU - Xing, J. AU - Wang, M. PY - 2018 DA - 2018// TI - Prognostic role of circulating tumor cells in patients with egfr-mutated or alk-rearranged non-small cell lung cancer JO - Thorac Cancer VL - 9 UR - https://doi.org/10.1111/1759-7714.12631 DO - 10.1111/1759-7714.12631 ID - Tong2018 ER - TY - JOUR AU - Gerber, D. E. AU - Socinski, M. A. AU - Neal, J. W. AU - Wakelee, H. A. AU - Shirai, K. AU - Sequist, L. V. AU - Rosovsky, R. P. AU - Lilenbaum, R. C. AU - Bastos, B. R. AU - Huang, C. PY - 2018 DA - 2018// TI - Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated kras mutant advanced non-small cell lung cancer JO - Lung Cancer VL - 117 UR - https://doi.org/10.1016/j.lungcan.2018.01.010 DO - 10.1016/j.lungcan.2018.01.010 ID - Gerber2018 ER - TY - JOUR AU - Wo, H. AU - He, J. AU - Zhao, Y. AU - Yu, H. AU - Chen, F. AU - Yi, H. PY - 2018 DA - 2018// TI - The efficacy and toxicity of gefitinib in treating non-small cell lung cancer: A meta-analysis of 19 randomized clinical trials JO - J Cancer VL - 9 UR - https://doi.org/10.7150/jca.23356 DO - 10.7150/jca.23356 ID - Wo2018 ER - TY - JOUR AU - Loubière, S. AU - Drezet, A. AU - Beau-Faller, M. AU - Moro-Sibilot, D. AU - Friard, S. AU - Wislez, M. AU - Blons, H. AU - Daniel, C. AU - Westeel, V. AU - Madroszyk, A. PY - 2018 DA - 2018// TI - Cost-effectiveness of kras, egfr and alk testing for decision making in advanced nonsmall cell lung carcinoma: the french ifct-predict. amm study JO - Eur Respir J VL - 51 UR - https://doi.org/10.1183/13993003.01467-2017 DO - 10.1183/13993003.01467-2017 ID - Loubière2018 ER - TY - JOUR AU - Ivkovic, T. C. AU - Voss, G. AU - Cornella, H. AU - Ceder, Y. PY - 2017 DA - 2017// TI - microRNAs as cancer therapeutics: a step closer to clinical application JO - Cancer Lett VL - 407 UR - https://doi.org/10.1016/j.canlet.2017.04.007 DO - 10.1016/j.canlet.2017.04.007 ID - Ivkovic2017 ER - TY - JOUR AU - Florczuk, M. AU - Szpechcinski, A. AU - Chorostowska-Wynimko, J. PY - 2017 DA - 2017// TI - mirnas as biomarkers and therapeutic targets in non-small cell lung cancer: Current perspectives JO - Targeted Oncol VL - 12 UR - https://doi.org/10.1007/s11523-017-0478-5 DO - 10.1007/s11523-017-0478-5 ID - Florczuk2017 ER - TY - STD TI - Burch C. Logisim: a graphical system for logic circuit design and simulation. J Educ Resour Comput. 2002; 2(1):5–16. https://doi.org/10.1145/545197.545199. ID - ref36 ER - TY - STD TI - Tolcher AW, Bendell JC, Papadopoulos KP, Burris HA, Patnaik A, Jones SF, Rasco D, Cox DS, Durante M, Bellew KM, Park J, Le NT, Infante JR. A phase ib trial of the oral mek inhibitor trametinib (gsk1120212) in combination with everolimus in patients with advanced solid tumors. Annals Oncol. 2015; 26(1):58–64. https://doi.org/10.1093/annonc/mdu482. ID - ref37 ER - TY - STD TI - WANG X, CAO L, WANG Y, WANG X, LIU N, YOU Y. Regulation of let-7 and its target oncogenes (review). Oncol Lett. 2012; 3(5):955–60. https://doi.org/10.3892/ol.2012.609. ol-03-05-0955[PII]. ID - ref38 ER - TY - STD TI - Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG, Slack FJ. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle. 2008; 7(6):759–64. https://doi.org/10.4161/cc.7.6.5834, PMID: 18344688, http://arxiv.org/abs/https://doi.org/10.4161/cc.7.6.5834. ID - ref39 ER - TY - STD TI - Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A. 2008; 105(10):3903–8. https://doi.org/10.1073/pnas.0712321105. 9461[PII]. ID - ref40 ER - TY - STD TI - Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004; 64(11):3753–6. https://doi.org/10.1158/0008-5472.CAN-04-0637. http://arxiv.org/abs/http://cancerres.aacrjournals.org/content/64/11/3753.full.pdf. ID - ref41 ER - TY - STD TI - Shah MY, Ferrajoli A, Sood AK, Lopez-Berestein G, Calin GA. MicroRNA therapeutics in cancer – an emerging concept. EBioMedicine. 2016; 12:34–42. https://doi.org/10.1016/j.ebiom.2016.09.017. S2352-3964(16)30423-6[PII]. ID - ref42 ER - TY - STD TI - Esposito CL, Cerchia L, Catuogno S, De Vita G, Dassie JP, Santamaria G, Swiderski P, Condorelli G, Giangrande PH, de Franciscis V. Multifunctional aptamer-mirna conjugates for targeted cancer therapy. Mol Ther. 2014; 22(6):1151–63. https://doi.org/10.1038/mt.2014.5. 24441398[pmid]. ID - ref43 ER - TY - STD TI - Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB, Slack FJ. Regression of murine lung tumors by the let-7 microRNA. Oncogene. 2010; 29(11):1580–7. https://doi.org/10.1038/onc.2009.445. 19966857[pmid]. ID - ref44 ER - TY - JOUR AU - Russo, A. E. AU - Torrisi, E. AU - Bevelacqua, Y. AU - Perrotta, R. AU - Libra, M. AU - McCubrey, J. A. AU - Spandidos, D. A. AU - Stivala, F. AU - Malaponte, G. PY - 2009 DA - 2009// TI - Melanoma: molecular pathogenesis and emerging target therapies JO - Int J Oncol VL - 34 ID - Russo2009 ER - TY - JOUR AU - Davies, H. AU - Bignell, G. R. AU - Cox, C. AU - Stephens, P. AU - Edkins, S. AU - Clegg, S. AU - Teague, J. AU - Woffendin, H. AU - Garnett, M. J. AU - Bottomley, W. PY - 2002 DA - 2002// TI - Mutations of the braf gene in human cancer JO - Nature VL - 417 UR - https://doi.org/10.1038/nature00766 DO - 10.1038/nature00766 ID - Davies2002 ER - TY - JOUR AU - Curtin, J. A. AU - Fridlyand, J. AU - Kageshita, T. AU - Patel, H. N. AU - Busam, K. J. AU - Kutzner, H. AU - Cho, K. -. H. AU - Aiba, S. AU - Bröcker, E. -. B. AU - LeBoit, P. E. PY - 2005 DA - 2005// TI - Distinct sets of genetic alterations in melanoma JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050092 DO - 10.1056/NEJMoa050092 ID - Curtin2005 ER - TY - JOUR AU - Coleman, M. L. AU - Marshall, C. J. AU - Olson, M. F. PY - 2004 DA - 2004// TI - Ras and rho gtpases in g1-phase cell-cycle regulation JO - Nat Rev Mol Cell Biol VL - 5 UR - https://doi.org/10.1038/nrm1365 DO - 10.1038/nrm1365 ID - Coleman2004 ER - TY - JOUR AU - Chudnovsky, Y. AU - Khavari, P. A. AU - Adams, A. E. PY - 2005 DA - 2005// TI - Melanoma genetics and the development of rational therapeutics JO - J Clin Investig VL - 115 UR - https://doi.org/10.1172/JCI24808 DO - 10.1172/JCI24808 ID - Chudnovsky2005 ER - TY - JOUR AU - Dankort, D. AU - Curley, D. P. AU - Cartlidge, R. A. AU - Nelson, B. AU - Karnezis, A. N. AU - Damsky Jr, W. E. AU - You, M. J. AU - DePinho, R. A. AU - McMahon, M. AU - Bosenberg, M. PY - 2009 DA - 2009// TI - Braf v600e cooperates with pten loss to induce metastatic melanoma JO - Nat Genet VL - 41 UR - https://doi.org/10.1038/ng.356 DO - 10.1038/ng.356 ID - Dankort2009 ER - TY - JOUR AU - Mueller, D. AU - Bosserhoff, A. PY - 2009 DA - 2009// TI - Role of mirnas in the progression of malignant melanoma JO - Br J Cancer VL - 101 UR - https://doi.org/10.1038/sj.bjc.6605204 DO - 10.1038/sj.bjc.6605204 ID - Mueller2009 ER - TY - JOUR AU - Davis, M. E. AU - Zuckerman, J. E. AU - Choi, C. H. J. AU - Seligson, D. AU - Tolcher, A. AU - Alabi, C. A. AU - Yen, Y. AU - Heidel, J. D. AU - Ribas, A. PY - 2010 DA - 2010// TI - Evidence of rnai in humans from systemically administered sirna via targeted nanoparticles JO - Nature VL - 464 UR - https://doi.org/10.1038/nature08956 DO - 10.1038/nature08956 ID - Davis2010 ER - TY - JOUR AU - Thyagarajan, A. AU - Shaban, A. AU - Sahu, R. P. PY - 2018 DA - 2018// TI - MicroRNA-directed cancer therapies: implications in melanoma intervention JO - J Pharmacol Exp Ther VL - 364 UR - https://doi.org/10.1124/jpet.117.242636 DO - 10.1124/jpet.117.242636 ID - Thyagarajan2018 ER - TY - JOUR AU - Schultz, J. AU - Lorenz, P. AU - Gross, G. AU - Ibrahim, S. AU - Kunz, M. PY - 2008 DA - 2008// TI - MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth JO - Cell Res VL - 18 UR - https://doi.org/10.1038/cr.2008.45 DO - 10.1038/cr.2008.45 ID - Schultz2008 ER - TY - JOUR AU - Sun, X. AU - Li, J. AU - Sun, Y. AU - Zhang, Y. AU - Dong, L. AU - Shen, C. AU - Yang, L. AU - Yang, M. AU - Li, Y. AU - Shen, G. PY - 2016 DA - 2016// TI - mir-7 reverses the resistance to brafi in melanoma by targeting egfr/igf-1r/craf and inhibiting the mapk and pi3k/akt signaling pathways JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.10669 DO - 10.18632/oncotarget.10669 ID - Sun2016 ER - TY - JOUR AU - Levati, L. AU - Alvino, E. AU - Pagani, E. AU - Arcelli, D. AU - Caporaso, P. AU - Bondanza, S. AU - Di Leva, G. AU - Ferracin, M. AU - Volinia, S. AU - Bonmassar, E. PY - 2009 DA - 2009// TI - Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of mirna-155 JO - Int J Oncol VL - 35 ID - Levati2009 ER - TY - JOUR AU - Svedman, F. C. AU - Lohcharoenkal, W. AU - Bottai, M. AU - Brage, S. E. AU - Sonkoly, E. AU - Hansson, J. AU - Pivarcsi, A. AU - Eriksson, H. PY - 2018 DA - 2018// TI - Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma JO - PloS ONE VL - 13 UR - https://doi.org/10.1371/journal.pone.0206942 DO - 10.1371/journal.pone.0206942 ID - Svedman2018 ER - TY - JOUR AU - Poell, J. B. AU - Van Haastert, R. J. AU - De Gunst, T. AU - Schultz, I. J. AU - Gommans, W. M. AU - Verheul, M. AU - Cerisoli, F. AU - Van Noort, P. I. AU - Prevost, G. P. AU - Schaapveld, R. Q. PY - 2012 DA - 2012// TI - A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability JO - PloS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0043569 DO - 10.1371/journal.pone.0043569 ID - Poell2012 ER - TY - JOUR AU - Yang, P. AU - Bu, P. AU - Li, C. PY - 2017 DA - 2017// TI - mir-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican JO - Exp Ther Med VL - 14 UR - https://doi.org/10.3892/etm.2017.4998 DO - 10.3892/etm.2017.4998 ID - Yang2017 ER - TY - JOUR AU - Maadi, H. AU - Moshtaghian, A. AU - Taha, M. F. AU - Mowla, S. J. AU - Kazeroonian, A. AU - Haass, N. K. AU - Javeri, A. PY - 2016 DA - 2016// TI - Multimodal tumor suppression by mir-302 cluster in melanoma and colon cancer JO - Int J Biochem Cell Biol VL - 81 UR - https://doi.org/10.1016/j.biocel.2016.11.004 DO - 10.1016/j.biocel.2016.11.004 ID - Maadi2016 ER - TY - JOUR AU - Popat, S. PY - 2018 DA - 2018// TI - Osimertinib as first-line treatment in EGFR-mutated non–small-cell lung cancer JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMe1714580 DO - 10.1056/NEJMe1714580 ID - Popat2018 ER - TY - JOUR AU - Buttitta, F. AU - Barassi, F. AU - Fresu, G. AU - Felicioni, L. AU - Chella, A. AU - Paolizzi, D. AU - Lattanzio, G. AU - Salvatore, S. AU - Camplese, P. P. AU - Rosini, S. PY - 2006 DA - 2006// TI - Mutational analysis of the her2 gene in lung tumors from caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features JO - Int J Cancer VL - 119 UR - https://doi.org/10.1002/ijc.22143 DO - 10.1002/ijc.22143 ID - Buttitta2006 ER - TY - JOUR AU - Ly, A. C. AU - Olin, J. L. AU - Smith, M. B. PY - 2018 DA - 2018// TI - Alectinib for advanced alk-positive non-small-cell lung cancer JO - Am J Health Syst Pharm VL - 75 UR - https://doi.org/10.2146/ajhp170266 DO - 10.2146/ajhp170266 ID - Ly2018 ER - TY - JOUR AU - Jin, G. AU - Kim, M. J. AU - Jeon, H. -. S. AU - Choi, J. E. AU - Kim, D. S. AU - Lee, E. B. AU - Cha, S. I. AU - Yoon, G. S. AU - Kim, C. H. AU - Jung, T. H. PY - 2010 DA - 2010// TI - Pten mutations and relationship to egfr, erbb2, kras, and tp53 mutations in non-small cell lung cancers JO - Lung Cancer VL - 69 UR - https://doi.org/10.1016/j.lungcan.2009.11.012 DO - 10.1016/j.lungcan.2009.11.012 ID - Jin2010 ER - TY - JOUR AU - Govindan, R. AU - Ding, L. AU - Griffith, M. AU - Subramanian, J. AU - Dees, N. D. AU - Kanchi, K. L. AU - Maher, C. A. AU - Fulton, R. AU - Fulton, L. AU - Wallis, J. PY - 2012 DA - 2012// TI - Genomic landscape of non-small cell lung cancer in smokers and never-smokers JO - Cell VL - 150 UR - https://doi.org/10.1016/j.cell.2012.08.024 DO - 10.1016/j.cell.2012.08.024 ID - Govindan2012 ER - TY - JOUR AU - Planchard, D. AU - Besse, B. AU - Groen, H. J. AU - Souquet, P. -. J. AU - Quoix, E. AU - Baik, C. S. AU - Barlesi, F. AU - Kim, T. M. AU - Mazieres, J. AU - Novello, S. PY - 2016 DA - 2016// TI - Dabrafenib plus trametinib in patients with previously treated brafv600e-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30146-2 DO - 10.1016/S1470-2045(16)30146-2 ID - Planchard2016 ER - TY - JOUR AU - Vansteenkiste, J. F. AU - Canon, J. -. L. AU - De Braud, F. AU - Grossi, F. AU - De Pas, T. AU - Gray, J. E. AU - Su, W. -. C. AU - Felip, E. AU - Yoshioka, H. AU - Gridelli, C. PY - 2015 DA - 2015// TI - Safety and efficacy of buparlisib (bkm120) in patients with pi3k pathway-activated non-small cell lung cancer: results from the phase ii basalt-1 study JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000607 DO - 10.1097/JTO.0000000000000607 ID - Vansteenkiste2015 ER - TY - JOUR AU - Deeb, K. K. AU - Hohman, C. M. AU - Risch, N. F. AU - Metzger, D. J. AU - Starostik, P. PY - 2015 DA - 2015// TI - Routine clinical mutation profiling of non–small cell lung cancer using next-generation sequencing JO - Arch Pathol Lab Med VL - 139 UR - https://doi.org/10.5858/arpa.2014-0095-OA DO - 10.5858/arpa.2014-0095-OA ID - Deeb2015 ER - TY - JOUR AU - Gridelli, C. AU - Maione, P. AU - Rossi, A. PY - 2008 DA - 2008// TI - The potential role of mtor inhibitors in non-small cell lung cancer JO - Oncologist VL - 13 UR - https://doi.org/10.1634/theoncologist.2007-0171 DO - 10.1634/theoncologist.2007-0171 ID - Gridelli2008 ER - TY - JOUR AU - Malanga, D. AU - Scrima, M. AU - De Marco, C. AU - Fabiani, F. AU - De Rosa, N. AU - De Gisi, S. AU - Malara, N. AU - Savino, R. AU - Rocco, G. AU - Chiappetta, G. PY - 2008 DA - 2008// TI - Activating e17k mutation in the gene encoding the protein kinase akt in a subset of squamous cell carcinoma of the lung JO - Cell Cycle VL - 7 UR - https://doi.org/10.4161/cc.7.5.5485 DO - 10.4161/cc.7.5.5485 ID - Malanga2008 ER - TY - JOUR AU - Marks, J. L. AU - Gong, Y. AU - Chitale, D. AU - Golas, B. AU - McLellan, M. D. AU - Kasai, Y. AU - Ding, L. AU - Mardis, E. R. AU - Wilson, R. K. AU - Solit, D. PY - 2008 DA - 2008// TI - Novel mek1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0099 DO - 10.1158/0008-5472.CAN-08-0099 ID - Marks2008 ER - TY - JOUR AU - Goldman, J. W. AU - Garon, E. B. PY - 2012 DA - 2012// TI - Targeting mek for the treatment of non small-cell lung cancer JO - J Thorac Oncol Off Publ Int Assoc Study Lung Cancer VL - 7 ID - Goldman2012 ER - TY - JOUR AU - Balla, A. AU - Khan, F. AU - Hampel, K. J. AU - Aisner, D. L. AU - Sidiropoulos, N. PY - 2018 DA - 2018// TI - Small-cell transformation of alk-rearranged non-small-cell adenocarcinoma of the lung JO - Mol Case Stud VL - 4 UR - https://doi.org/10.1101/mcs.a002394 DO - 10.1101/mcs.a002394 ID - Balla2018 ER - TY - JOUR AU - Champion, K. AU - Bunag, C. AU - Estep, A. AU - Jones, J. AU - Bolt, C. AU - Rogers, R. AU - Rauen, K. AU - Everman, D. PY - 2011 DA - 2011// TI - Germline mutation in braf codon 600 is compatible with human development: de novo p. v600g mutation identified in a patient with cfc syndrome JO - Clin Genet VL - 79 UR - https://doi.org/10.1111/j.1399-0004.2010.01495.x DO - 10.1111/j.1399-0004.2010.01495.x ID - Champion2011 ER - TY - JOUR AU - Chang, M. T. AU - Asthana, S. AU - Gao, S. P. AU - Lee, B. H. AU - Chapman, J. S. AU - Kandoth, C. AU - Gao, J. AU - Socci, N. D. AU - Solit, D. B. AU - Olshen, A. B. PY - 2016 DA - 2016// TI - Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity JO - Nat Biotechnol VL - 34 UR - https://doi.org/10.1038/nbt.3391 DO - 10.1038/nbt.3391 ID - Chang2016 ER - TY - JOUR AU - van’t Veer, L. J. AU - Burgering, B. AU - Versteeg, R. AU - Boot, A. AU - Ruiter, D. AU - Osanto, S. AU - Schrier, P. AU - Bos, J. PY - 1989 DA - 1989// TI - N-ras mutations in human cutaneous melanoma from sun-exposed body sites JO - Mol Cell Biol VL - 9 UR - https://doi.org/10.1128/MCB.9.7.3114 DO - 10.1128/MCB.9.7.3114 ID - van’t Veer1989 ER - TY - JOUR AU - Shi, H. AU - Hong, A. AU - Kong, X. AU - Koya, R. C. AU - Song, C. AU - Moriceau, G. AU - Hugo, W. AU - Clarissa, C. Y. AU - Ng, C. AU - Chodon, T. PY - 2014 DA - 2014// TI - A novel akt1 mutant amplifies an adaptive melanoma response to BRAF inhibition JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0279 DO - 10.1158/2159-8290.CD-13-0279 ID - Shi2014 ER - TY - STD TI - Mirzaa G, Conway R, Graham Jr JM, Dobyns WB. Pik3ca-related segmental overgrowth. Seattle; 2013. ID - ref78 ER - TY - JOUR AU - Nikolaev, S. I. AU - Rimoldi, D. AU - Iseli, C. AU - Valsesia, A. AU - Robyr, D. AU - Gehrig, C. AU - Harshman, K. AU - Guipponi, M. AU - Bukach, O. AU - Zoete, V. PY - 2012 DA - 2012// TI - Exome sequencing identifies recurrent somatic map2k1 and map2k2 mutations in melanoma JO - Nat Genet VL - 44 UR - https://doi.org/10.1038/ng.1026 DO - 10.1038/ng.1026 ID - Nikolaev2012 ER - TY - JOUR AU - Bartsch, D. K. AU - Sina-Frey, M. AU - Lang, S. AU - Wild, A. AU - Gerdes, B. AU - Barth, P. AU - Kress, R. AU - Grützmann, R. AU - Colombo-Benkmann, M. AU - Ziegler, A. PY - 2002 DA - 2002// TI - Cdkn2a germline mutations in familial pancreatic cancer JO - Ann Surg VL - 236 UR - https://doi.org/10.1097/00000658-200212000-00005 DO - 10.1097/00000658-200212000-00005 ID - Bartsch2002 ER -